← Leaderboards
K Craig Kent
Weill Medical College Of Cornell Univ
$12,068,465
Attributed
$17,309,292
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,010,068 · 13
AHRQ$299,224 · 1
By mechanism
R01$14,096,524 · 8
T32$2,793,307 · 4
R21$299,224 · 1
R29$120,237 · 1
Top collaborators
- Lianwang Guo14 shared
- Shaoqin - Gong12 shared
- Coleen A Mcnamara1 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Ching-Hwa Sung$16,119,446
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsHyperplasiaMorbidity - Disease RateSmooth Muscle MyocytesMediatingReconstructionFunctional DisorderBypassArteriesPreventVascular DiseasesAngioplastyPhenotypeDesignIn VivoCell ProliferationOperative Surgical ProceduresLesionPathway InteractionsInhibitor/AntagonistRestenosisAffectSignal TransductionCollagen
Grant awards (51)
Mechanistic and Translational Determination of PERK-targeting Strategies for Non-surgical Management of Abdominal Aortic Aneurysm$690,384
R01 · FY2025 · HL · contact PI
Epigenetic targeting and nanoplatform-enabled local drug delivery - a two-pronged approach to stenosis prevention after vascular surgery$729,244
R01 · FY2024 · HL
Targeted approach to the mitigation of abdominal aortic aneurysm$724,978
R01 · FY2024 · HL
Targeted suppression of ALDH1A3 for endothelial beneficial management of restenosis after vascular surgery$719,626
R01 · FY2024 · HL · contact PI
Mechanistic and Translational Determination of PERK-targeting Strategies for Non-surgical Management of Abdominal Aortic Aneurysm$678,529
R01 · FY2024 · HL · contact PI
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery$634,517
R01 · FY2021 · HL · contact PI
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery$595,265
R01 · FY2020 · HL
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery$595,265
R01 · FY2019 · HL
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction$313,866
R01 · FY2019 · HL
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction$168,300
R01 · FY2019 · HL · contact PI
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery$609,265
R01 · FY2018 · HL · contact PI
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction$483,556
R01 · FY2018 · HL · contact PI
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction$496,555
R01 · FY2017 · HL · contact PI
TGF-beta and Smad3 in intimalhyperplasia after vascular bypass$387,292
R01 · FY2017 · HL · contact PI
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction$553,250
R01 · FY2016 · HL · contact PI
TGF-beta and Smad3 in intimal hyperplasia after vascular bypass$372,210
R01 · FY2016 · HL · contact PI
Vascular Surgery Research Training Program$246,093
T32 · FY2016 · HL · contact PI
TGF-beta and Smad3 in intimal hyperplasia after vascular bypass$366,626
R01 · FY2015 · HL · contact PI
Vascular Surgery Research Training Program$262,158
T32 · FY2015 · HL · contact PI
TGF-beta and Smad3 in intimal hyperplasia after vascular bypass$372,210
R01 · FY2014 · HL · contact PI
Patient-Centered Postoperative Wound Surveillance Using Current Technology$299,224
R21 · FY2014 · HS · contact PI
Vascular Surgery Research Training Program$258,140
T32 · FY2014 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$349,896
R01 · FY2013 · HL · contact PI
Vascular Surgery Research Training Program$253,293
T32 · FY2013 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$383,151
R01 · FY2012 · HL · contact PI
Vascular Surgery Research Training program$124,616
T32 · FY2012 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$371,250
R01 · FY2011 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$43,139
R01 · FY2011 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$371,250
R01 · FY2010 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$59,013
R01 · FY2010 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$59,946
R01 · FY2009 · HL · contact PI
TGF-beta in intimal hyperplasia after vascular bypass$371,250
R01 · FY2008 · HL · contact PI
PKC-Delta in Intimal Hyperplasia after Vascular Bypass$398,236
R01 · FY2007 · HL · contact PI
Multidisciplinary Vascular Surgery Research Training Program$230,630
T32 · FY2007 · HL · contact PI
TRAUMA AND INJURY BIOLOGY RESEARCH TRAINING PROGRAM$1
T32 · FY2007 · GM · contact PI
PKC-Delta in Intimal Hyperplasia after Vascular Bypass$410,130
R01 · FY2006 · HL · contact PI
Multidisciplinary Vascular Surgery Research Training Program$237,661
T32 · FY2006 · HL · contact PI
TRAUMA AND INJURY BIOLOGY RESEARCH TRAINING PROGRAM$164,432
T32 · FY2006 · GM · contact PI
PKC-Delta in Intimal Hyperplasia after Vascular Bypass$420,000
R01 · FY2005 · HL
TGF-Beta in Intimal Hyperplasia after Vascular Bypass$331,067
R01 · FY2005 · HL
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$208,612
T32 · FY2005 · CA
TRAUMA AND INJURY BIOLOGY RESEARCH TRAINING PROGRAM$162,812
T32 · FY2005 · GM
TGF-Beta in Intimal Hyperplasia after Vascular Bypass$331,067
R01 · FY2004 · HL
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$163,290
T32 · FY2004 · CA
TGF-Beta in Intimal Hyperplasia after Vascular Bypass$361,352
R01 · FY2003 · HL
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$222,214
T32 · FY2003 · CA
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$56,803
T32 · FY2003 · CA
TGF-Beta in Intimal Hyperplasia after Vascular Bypass$331,067
R01 · FY2002 · HL
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$202,552
T32 · FY2002 · CA
TGF-Beta in Intimal Hyperplasia after Vascular Bypass$13,772
R01 · FY2002 · HL
SMOOTH MUSCLE MIGRATION AFTER VASCULAR RECONSTRUCTION$120,237
R29 · FY2000 · HL